TE_37233
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | SVA_A |
|---|---|
| TE superfamily | SVA |
| TE class | Retroposon |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 0.06 |
| Counts of samples | TCGA_tumor:12; TCGA_normal:0; GTEx:259 |
| TSS | chr22(-):50166773 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_37233.1 | - | Intergenic | Non-coding | Non-coding | chr22(-):50165814,50165834,50165883,50166022,50166623,50166774 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
